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Anterior cruciate ligament (ACL) reconstruction restores knee stability but does not reduce the incidence of posttraumatic
osteoarthritis induced by inflammatory cytokines. The aim of this research was to longitudinally measure IL-1𝛽, IL-6, IL-8, IL-10,
and TNF-𝛼 levels in patients subjected to ACL reconstruction using bone-patellar tendon-bone graft. Synovial fluid was collected
within 24–72 hours of ACL rupture (acute), 1 month after injury immediately prior to surgery (presurgery), and 1 month thereafter
(postsurgery). For comparison, a “control” group consisted of individuals presenting chronic ACL tears. Our results indicate that
levels of IL-6, IL-8, and IL-10 vary significantly over time in reconstruction patients. In the acute phase, the levels of these cytokines
in reconstruction patients were significantly greater than those in controls. In the presurgery phase, cytokine levels in reconstruction
patients were reduced and comparable with those in controls. Finally, cytokine levels increased again with respect to control group
in the postsurgery phase. The levels of IL-1𝛽 and TNF-𝛼 showed no temporal variation. Our data show that the history of an ACL
injury, including trauma and reconstruction, has a significant impact on levels of IL-6, IL-8, and IL-10 in synovial fluid but does
not affect levels of TNF-𝛼 and IL-1𝛽.
1. Introduction
Anterior cruciate ligament (ACL) injuries represent approx-
imately 25% of all knee injuries with an annual incidence of
at least 0.8 per 1000 persons aged between 10 and 64 years
[1]. Nowadays more than 175,000 ACL reconstructions are
performed in the US annually [1, 2]. ACL reconstruction
can provide knee stability, permit continued participation
in sports, and reduce the incidence of other intra-articular
knee injuries, such as meniscal and chondral lesions [3–
6]. An association between delaying ACL surgery and the
development of subsequent meniscal tears and chondral
lesions has been well documented in adults and skeletally
immature patients [5, 6]. This consequence could depend on
an excessive anterior tibial translation and a rotational insta-
bility in the injured knee. Presently, graft choices for primary
ACL reconstruction include patellar tendon-bone (BPTB)
and hamstring (HT) autografts [7]. Even though BPTB auto-
grafts may be better in restoring stability than HT autografts,
knee-joint stability restored by ACL reconstruction does not
decrease the incidence of posttraumatic osteoarthritis (OA)
[4, 7, 8]. Fifty to 60% of patients with ACL-reconstructed
knees have radiographic evidence of OA after five years
[8, 9]. This observation suggests the importance of other
factors in the pathophysiology of posttraumaticOAafterACL
injuries, including intra-articular inflammatory reactions.
High levels of inflammatory cytokines (interleukins, ILs)
such as interleukin-1𝛽 (IL-1𝛽), interleukin-6 (IL-6), and
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tumor necrosis factor-𝛼 (TNF-𝛼) have been detected in
acute and chronic anterior cruciate ligament injured knees,
suggesting that cytokines can promote cartilage catabolism
through the synthesis of free radicals and metalloproteases
(MMPs) and consequently participate in OA development
[9–11]. Biochemical changes in the synovial fluid of ACL-
damaged knees have been extensively reported, but the evolv-
ing joint biochemical processes are not clearly documented
[12, 13]. These studies examined cytokines or MMPs in the
knee joint in a specific clinical situation such as acute or
chronic injury but did not follow these levels longitudinally
in individual patients undergoing ACL reconstruction. As
there are large variations in absolute levels of synovial fluid
cytokines among similarly compromised patients [9, 10], it
is critical to track individual patients longitudinally to deter-
mine if there are different patient-specific cytokine responses.
In this study, we examined knee joint inflammatory
patterns in each patient (i) within 24–72 hours of ACL
rupture (acute), (ii) 1 month after injury immediately prior
to arthroscopic ACL reconstruction surgery (presurgery),
and (iii) 1 month thereafter (postsurgery). In particular,
we measured the concentrations of selected pro- and anti-
inflammatory cytokines (IL-1𝛽, IL-6, IL-8, IL-10, and TNF-
𝛼) in the synovial fluid. For comparison, a corresponding
“control” group consisted of individuals (𝑛 = 17) presenting
chronic ACL tears. The aim of the present study was to better
understand how cytokines profiles evolve in the same patient
after ACL rupture and after ACL reconstruction with BPTB.
2. Methods
2.1. Participants. Eightmale participants aged between 18 and
40 years (mean: 24.5±7.5 years) presentingACL injurywithin
72 hours were recruited by an orthopedic surgeon for the
periacute ACL tear group. Inclusion criteria consisted of an
isolated ACL tear, or an ACL tear associated with a meniscal
tear (not itself requiring surgical treatment) confirmed by
a senior orthopedic surgeon using present history, physical
examination (including positive Lachman and Pivot Shift
tests), magnetic resonance imaging, and a confirmation by
arthroscopic examination. In comparison, 17 male patients
(mean age: 32.6 ± 9.05 years; 5 patients with isolated ACL
tear and 12 patients with associated meniscal tear) were
recruited from the local community and selected for a chronic
ACL tear (3 months or more from the trauma as previously
defined) confirmed clinically, with a MRI and arthroscopic
surgery [11]. These chronic ACL tear subjects were pooled
as concentrations of IL-1𝛽, IL-6, IL-8, IL-10, and TNF-𝛼 are
independent of associated meniscal injury [11]. Individuals
were excluded from either group if they had a previous
history of knee injury, bone fractures simultaneously at
investigated knee sprain, chondral lesion or chondropathy
with a grade ≥ II according to Outerbridge classification,
inflammatory arthritis, osteochondral lesion, and previous
intra-articular injection of steroid or hyaluronic acid or
NSAID treatment.
Synovial fluid was collected from participants of the
periacute ACL tear group 3 times: (i) acute: 24–72 hours
from the ACL rupture, (ii) presurgery: 1 month after the acute
event (when an arthroscopic ACL reconstruction surgery was
planned); and (iii) postsurgery: 1 month after the surgery.
Arthroscopic ACL reconstruction was performed using
bone-patellar tendon-bone (BTB) graft by the senior sur-
geon (Marco Bigoni). Femoral fixation was performed with
two bioabsorbable cross-pins using RigidFix (DePuy Mitek,
Raynham,MA, USA) and tibial fixation with a bioabsorbable
interference screw (9 × 23mm; DePuy Mitek, Raynham,
MA, USA). After surgery, all patients followed the same
accelerated rehabilitation protocol focusing on quadriceps
recruitment and early gain of full range of motion. In the
chronicACLgroup, synovial fluidwas drawn at the beginning
of arthroscopic surgery.
Protocols were approved by the local Human Research
Ethical Committee and conformed to the principles outlined
in the WMA Declaration of Helsinki. All participants pro-
vided written informed consent.
2.2. Samples. Synovial fluid was aseptically collected without
lavage at the beginning of arthroscopic surgery or during
initial clinical reception in the emergency room. Synovial
fluid samples, collected in tubes containing EDTA, were
immediately centrifuged at room temperature (3,000 g ×
10min) in order to remove cellular debris and the supernatant
was stored at −80∘C until being assayed [10, 11]. The levels of
interleukins (IL-1𝛽, IL-6, IL-8, and IL-10) and tumor necro-
sis factor (TNF-𝛼) were measured using specific sandwich
enzyme-linked immunosorbent assay (ELISA) according to
the manufacturer’s instructions (IL-1𝛽, IL-10, and TNF-𝛼,
R&D Systems, Minneapolis, MN; IL-6 and IL-8, eBioscience,
San Diego, CA). Detection limits were 2.2 pg/mL, 0.8 pg/mL,
0.5 pg/mL, 2 pg/mL, and 1 pg/mL, respectively, for IL-6, IL-8,
TNF-𝛼, IL-10, and IL-1𝛽.
2.3. Statistical Analysis. Statistical analysis was performed
using MATLAB (version R2010b; MathWorks). Normality of
data distribution was assessed by the Jarque-Bera test. Since
data were not normally distributed, nonparametric tests were
performed.
When comparing temporal patterns, the Kruskal-Wallis
test for statistical difference between 3 groups (i.e., acute,
presurgery, and postsurgery) was performed, which is a
nonparametric version of classical one-way ANOVA. In the
case of significance,Mann-Whitney test Bonferroni corrected
has been performed as post hoc analysis. When comparing
the periacute ACL tear group of patients and the chronic
ACL tear group in the different temporal sampling, the
Mann-Whitney test was used, which is the nonparametric
formulation of the 𝑡-test, Bonferroni corrected for multiple
comparison. For all statistical tests, 𝑝 values < 0.05 appropri-
ately corrected for multiple comparison where needed were
considered to be statistically significant.
For all statistical tests, since they were Bonferroni cor-
rected for multiple comparisons, values of 𝑝 < 0.0167 were
considered to be statistically significant.
3. Results
3.1. Effects of Trauma on Cytokine Levels in Synovial Fluids.
Measurement of cytokines levels in samples obtained shortly
Mediators of Inflammation 3
Table 1: Cytokine levels in synovial fluids from longitudinal ACL group and from chronic ACL tear group.
IL-6 (pg/mL) IL-8 (pg/mL) TNF-𝛼 (pg/mL) IL-10 (pg/mL) IL-1𝛽 (pg/mL)
Longitudinal ACL group
Acute samples 612.19 ± 124.98∗ 362.3 ± 164.60∗ 1.35 ± 0.52 29.09 ± 1.19∗ 9.07 ± 5.18
Presurgery samples 163.34 ± 106.35 38.22 ± 26.05 2.47 ± 0.56 8.82 ± 2.05 12.94 ± 6.35
Postsurgery samples 855.37 ± 183.12∗ 407.48 ± 109.71∗ 2.4 ± 0.48 11.21 ± 2.03∗ 9.42 ± 3.07
Chronic ACL tear group
Samples 58.52 ± 5.86 23.66 ± 1.55 6.15 ± 0.45 4.03 ± 0.21 6.15 ± 0.81
Cytokine concentrations (pg/mL) in the synovial fluid of patients of the longitudinal group (𝑛 = 8) and chronic ACL tears (𝑛 = 17). Samples of longitudinal
group were further assigned to groups according to the moment of the synovial fluid collection: acute samples (less than 72 hours after ACL injury); presurgery
samples (1 month after the trauma, just before the arthroscopic ACL reconstruction surgery); postsurgery samples (1 month after the surgery). Values are
expressed as mean ± standard error of the mean (SEM). ∗Statistically significant periacute samples in comparison with chronic ACL tear group.
after ACL tear confirms the picture of an inflammatory acute
reaction. In fact, levels of IL-6 were significantly higher (𝑝 <
0.001) compared to the chronic ACL tear group (Table 1).
Similarly, also IL-8 levels were significantly higher (𝑝 <
0.001) in the acute samples compared to the chronic ACL tear
group (Table 1). Compared to chronic ACL group, IL-8 and
IL-6 levels were elevated 15- and 11-fold, respectively (Table 1).
IL-10 levels were also increased but to a lesser extent (𝑝 <
0.001), whereas IL-1𝛽 and TNF-𝛼 levels were comparable in
acute samples and chronic ACL group (Table 1).
3.2. Temporal Patterns. Surgical trauma for ACL reconstruc-
tion clearly stimulated a recurrence of the inflammatory
picture, causing IL-6, IL-8, and IL-10 concentrations to follow
a “V-shaped” trend (i.e., high-low-high values) (Figure 2).
Indeed, acute and postsurgery IL-6, IL-8, and IL-10 levels
result in being significantly higher with respect to the chronic
ACL tear group (Figure 2). In the presurgery phase, synovial
fluid levels of IL-6, IL-8, and IL-10 displayed a rapid decrease
(Figure 1), so that 30 days after injury they were in the range
of those measured in chronic ACL group (Table 1). IL-1𝛽
and TNF-𝛼 levels in each sample of longitudinal group were
similar with respect to chronic ACL tear group at any time
(Figure 2) and did not follow a specific trend correlated with
time after injury (Figure 1). In particular, post hoc analysis
demonstrated that in the presurgery assessment IL-6 and IL-
8 concentrations are significantly lower with respect to acute
assessment (𝑝 = 0.0111), and in postsurgery assessment their
levels significantly increased (𝑝 = 0.0111; 𝑝 = 0.0041).
Similarly, we measured a significant decrease of IL-10 levels
from the acute to presurgery samples (𝑝 < 0.001).
4. Discussion
Acute ACL injuries establish an inflammatory reaction that
persists chronically after resolution of the acute effusion
[10, 14, 15]. Knee-joint inflammatory cytokines can promote
cartilage catabolism through the synthesis of free radicals
and metalloproteases and develop OA [16, 17]. Moreover,
cytokine-mediated inflammatory responses could play an
important role in bone tunnel enlargement following ACL
reconstruction.
Cytokines as IL-6, IL-8, and IL-1𝛽 promote osteoclastic
activity and can contribute to bone resorption [18]. In
a rabbit model, it was described that interarticular bone
tunnel healing was slower and less complete in the articular
part of the tunnel, suggesting an important role of the
synovial environment in the graft integration [19].
Different studies reported high pathological levels of
cytokines in the synovial fluid after ACL injury, chronically,
and after ACL reconstruction, but to our knowledge the
biological natural history of an ACL tear with multiple
synovial fluid collections remains uninvestigated [9, 10, 13].
IL-6 and IL-8 are proinflammatory cytokines with an
important role in cartilage and bone damage. IL-6 in the
joint environment reduces the production of type II collagen,
increases the production of MMPS, and is considered to
be the key cytokine in the subchondral bone degradation
[17, 20].Moreover, in vitromodels showed that IL-6 role in the
cartilage destruction is markedly potentiated by mechanical
injury [21]. IL-6 has the capability to increase the production
of inflammatory chemokines, such as IL-8 in synoviocytes
and monocytes [22].
IL-8 is a potent chemokine with a key function in
the promotion of neutrophil-mediated inflammation and
cartilage destruction [23]. These two cytokines present a
specific and similar trend in response to the articular events.
Immediately after the ACL rupture, IL-6 and IL-8 levels
largely increased compared to the chronic ACL tear group.
Interestingly, 1 month after IL-6 and IL-8 levels decreased
while remaining higher than in the chronic control group.
The ACL reconstruction, the presence of foreign bodies and
allograft, and the accelerated rehabilitation protocol caused
postsurgery levels of IL-6 to increase more than fivefold
compared to the presurgery levels. Similarly, also postsurgery
levels of IL-8 increased more than tenfold compared to the
presurgery levels. This could suggest a role for IL-8 and IL-6
not only in the very early phase of joint inflammation but in
all the biological history of a knee with an ACL injury and
reconstruction.
IL-10 is a modulator cytokine that contributes to the
suppression of the inflammation of the synovial membrane
and is endowed with chondroprotective properties. It stim-
ulates the synthesis of type II collagen and aggrecan and
antagonizes the release of MMP in chondrocyte [17]. We
found high levels of IL-10 in acute samples compared to
chronic ACL tear group as previously reported [11]. One
month later, IL-10 levels decreased more than threefold
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Figure 1: Cytokine levels in the synovial fluid of individual patients after ACL rupture. Squares represent values measured in single subjects
(𝑛 = 8); each subject is represented with different grey values. Acute (less than 72 hours after ACL injury); pre (1 month after the trauma, in
or before the arthroscopic ACL reconstruction surgery); post (1 month after the surgery).
from the acute ACL injury. The intra-articular stress that
follows ACL reconstruction does not stimulate an increase
in IL-10 capable of maintaining its levels in time higher
than those measured in chronic ACL tear patients. Helmark
and colleagues showed an increase in intra-articular IL-10
concentration secondary to specific exercise in patient with
knee OA, suggesting an important dependence of the IL-10
production on muscular exercises [24]. Following 1 month of
accelerated rehabilitation protocol, we also reported a slight
trend towards higher concentrations of IL-10 postoperatively.
Cameron and colleagues observed that their patients
could be divided into two subgroups when considering
the synovial concentrations of IL-1𝛽 and TNF-𝛼 in ACL-
deficient knees. One group presented levels of IL-1𝛽 and
TNF-𝛼 that were high acutely after trauma and decreased
to zero in time, whereas the other group had low levels of
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Figure 2: Time-relatedmodifications of cytokine levels compared to chronic ACL group. Cytokine concentrationsmeasured at different time
points in the longitudinal group (𝑛 = 8) are represented in the box-plot. In each box-plot, the box is built within the third (upper bound) and
first (lower bound) quartiles (i.e., 𝑄
3
, 𝑄
1
); the middle line represents the median. Whiskers represent data maximum (upper whisker) and
minimum (lower whisker). + indicates data outliers, defined as data points below 𝑄
1
− 1.5 × (𝑄
3
− 𝑄
1
) or above 𝑄
3
+ 1.5 × (𝑄
3
− 𝑄
1
). Grey
shaded area represents the interquartile range of the chronic ACL tear group (𝑛 = 17).
these cytokines both acutely after trauma and four weeks
postoperatively [25]. Based on these data, they speculated
that on the basis of their IL-1𝛽 and TNF-𝛼 profiles patients
could be at different risk of developing posttraumatic OA.
However, data demonstrating that patients with high levels
of IL-1𝛽 and TNF-𝛼 following acute ACL rupture have
a higher incidence of OA compared to those presenting
low levels of these inflammatory cytokines are still lacking.
The data that we have obtained in the present study cannot
support Cameron’s hypothesis given the small size of the
patient population. Even if IL-1𝛽 and TNF-𝛼 are two of the
most studied and important cytokines in the pathophysiology
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of OA, more studies to understand their specific role in
ACL tear patients are required. Our data showed acute
levels of IL-1𝛽 and TNF-𝛼 comparable to presurgery levels
and postsurgery levels. Essentially, no differences can be
reported between longitudinal ACL group and control group,
in agreement with previous literature. Indeed, Zysk and
coworkers investigated the synovial fluid concentrations of
three proinflammatory cytokines (TNF-𝛼, IL-1𝛽, and IL-6)
before ACL surgery (24±7 days after ACL rupture) and 7 days
after the surgical operation. They reported that IL-6 levels
increased significantly from the pre- to the postoperative
measurements whereas IL-1𝛽 and TNF-𝛼 concentrations
remained unchanged throughout the course of ACL surgery
[18].
Interestingly, in vitro studies reported that cytokines as
IL-1𝛽 and TNF-𝛼 have a role in stimulating the synthesis
of other cytokines such as IL-6 and IL-8. However different
cytokine trends in response to articular events underline
the complexity of multiple cascades that could stimulate the
synthesis and release of specific cytokines [23].
We are aware of some limitations of the results obtained in
this study. We present the data obtained in a limited number
of patients, but the prospective design of this pilot study, the
strict criteria of samples collection, and storage and analysis
and surgicalmanagement are very positive aspects.Moreover,
we had no access to synovial samples from healthy knees for
ethical reasons, and to obviate to this problem we choose to
compare data with those of a group of patients with chronic
ACL tears.
5. Conclusion
This pilot study is to our knowledge the first one describing
the temporal evolution of synovial IL-6, IL-8, IL-1𝛽, IL-10,
and TNF-𝛼 concentrations from the time of ACL rupture
to the postsurgical follow-up in the same patients. These
data suggest that ACL injury and ACL surgery have a great
impact on IL-6, IL-8, and IL-10 levels in the synovial fluid.
TNF-𝛼 and IL-1𝛽 levels in synovial fluid followed a different
temporal pattern, since they did not increase following acute
ACL injury and remained unaltered in time despite the ACL
reconstruction surgery.
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